Ripretinib
Author(s) -
Silpa S. Kumar,
Arun Philip,
K Pavithran
Publication year - 2021
Publication title -
cancer research statistics and treatment
Language(s) - Uncategorized
Resource type - Journals
eISSN - 2590-3233
pISSN - 2590-3225
DOI - 10.4103/crst.crst_308_20
Subject(s) - pdgfra , medicine , tyrosine kinase inhibitor , gist , tyrosine kinase , receptor tyrosine kinase , imatinib , platelet derived growth factor receptor , gastrointestinal tract , cancer research , stromal cell , imatinib mesylate , targeted therapy , oncology , receptor , growth factor , cancer , myeloid leukemia
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom